Results 261 to 270 of about 182,642 (309)
Some of the next articles are maybe not open access.
Veterinary Immunology and Immunopathology, 2002
The skin has long been recognized as a major producer of cytokines, but the keratinocyte as principal epidermal cell has received less attention as potential source and target of cytokines. Nevertheless, keratinocytes produce a plethora of cytokines including interleukin (IL)-1, -6, -7, -8, -10, -12, -15, -18, and -20, and tumor necrosis factor alpha ...
openaire +2 more sources
The skin has long been recognized as a major producer of cytokines, but the keratinocyte as principal epidermal cell has received less attention as potential source and target of cytokines. Nevertheless, keratinocytes produce a plethora of cytokines including interleukin (IL)-1, -6, -7, -8, -10, -12, -15, -18, and -20, and tumor necrosis factor alpha ...
openaire +2 more sources
Keratinocyte Carcinogenesis: Introduction
1993Skin keratinocytes may give rise to a broad variety of benign and malignant epithelial tumors. Among these, basal cell carcinoma and squamous cell carcinoma are the most frequent. Up to 60% of squamous cell carcinomas are preceded by precancerous lesions, mostly by actinic keratoses and rarely by Bowen’s disease.
openaire +2 more sources
Archives of Dermatology, 1993
Gene therapy is currently being used in clinical trials to treat a variety of diseases. In keratinocyte gene therapy, the gene that will correct the disease by expressing the normal protein or enzyme is inserted and expressed in keratinocytes. Keratinocytes have significant potential, as a target cell of gene therapy, in the treatment of both systemic ...
openaire +2 more sources
Gene therapy is currently being used in clinical trials to treat a variety of diseases. In keratinocyte gene therapy, the gene that will correct the disease by expressing the normal protein or enzyme is inserted and expressed in keratinocytes. Keratinocytes have significant potential, as a target cell of gene therapy, in the treatment of both systemic ...
openaire +2 more sources
2017
Keratinocyte cancers (KC) include basal and squamous cell carcinomas that arise from keratinocytes or their precursors. KCs are the most common malignancies in humans. Basal cell carcinoma (BCC) has higher incidence rates, but squamous cell carcinoma (SCC) causes most deaths.
Anala Gossai +4 more
openaire +1 more source
Keratinocyte cancers (KC) include basal and squamous cell carcinomas that arise from keratinocytes or their precursors. KCs are the most common malignancies in humans. Basal cell carcinoma (BCC) has higher incidence rates, but squamous cell carcinoma (SCC) causes most deaths.
Anala Gossai +4 more
openaire +1 more source
The incidence and multiplicity rates of keratinocyte cancers in Australia
Medical Journal of Australia, 2017N. Pandeya, C. Olsen, D. Whiteman
semanticscholar +1 more source
Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036
European Journal of Cancer, 2021Claus Garbe, Ulrike Keim, Sara Gandini
exaly
JAMA
Importance Keratinocyte carcinomas are skin cancers that arise from keratinocytes and are composed of basal cell carcinomas (BCCs) and cutaneous squamous cell carcinomas (cSCCs). Keratinocyte carcinomas are common in North America, Australia, New Zealand, and Europe.
openaire +1 more source
Importance Keratinocyte carcinomas are skin cancers that arise from keratinocytes and are composed of basal cell carcinomas (BCCs) and cutaneous squamous cell carcinomas (cSCCs). Keratinocyte carcinomas are common in North America, Australia, New Zealand, and Europe.
openaire +1 more source